Received May 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y014095 | — |
No additional AE reported; administration of MMRII after a temperature excursion; This Spontaneous report was received from Nurse and referred to a patient of unknown age and gender. The patient's medical history was not reported. The patient's past medications were not reported. The patient's concomitant medications were not reported. On 16-Feb-2026, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) injection (lot # Y014095, expiration date 19-Aug-2026, dose, route were not reported) for prophylaxis after a temperature excursion (Product storage issue). Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was reconstituted with sterile diluent (HOLLISTER-STIER STERILE DILUENT) (lot# and expiry date was not reported). The product underwent a temperature excursion of -6.7 degrees Celsius for 42 minutes. There was no previous temperature excursion. No additional adverse event reported. This is one of the several reports from the same reporter.
sterile diluent